Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Crossover Study of Propranolol Versus Ivabradine in Postural Tachycardia Syndrome (POTS)

NCT04186286 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04186286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04186286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Crossover Study of Propranolol Versus Ivabradine in Postural Tachycardia Syndrome (POTS)
Lead sponsor
University of Calgary
Phase
Phase 2
Overall status
Recruiting
Start date
February 1, 2021
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postural tachycardia syndrome